Dynamic association of p300 with the promoter of the G protein-coupled rat delta opioid receptor gene during NGF-induced neuronal differentiation

Biochemical and Biophysical Research Communications

Volumn 396, Issue 2, 2010, Pages 294-298

  Chen, Yulong L ^a   Monteith, Nancy ^a   Law, Ping Y ^b   Loh, Horace H ^b  

^a BINGHAMTON UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

GPCR; Neuronal differentiation; NF B; NGF; p300; RNA polymerase II

Indexed keywords

DELTA OPIATE RECEPTOR; DNA; G PROTEIN COUPLED RECEPTOR; HISTONE; HISTONE ACETYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSINE; NERVE GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P300; RNA POLYMERASE II;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DNA MODIFICATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; MOLECULAR CLONING; NERVE CELL DIFFERENTIATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BASE SEQUENCE; CLONING, MOLECULAR; E1A-ASSOCIATED P300 PROTEIN; NERVE GROWTH FACTOR; NEUROGENESIS; NEURONS; PC12 CELLS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTORS, OPIOID, DELTA; RNA POLYMERASE II; SEQUENCE DELETION;

RATTUS;

EID: 77952741764     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.04.083     Document Type: Article

References (35)

1. Chao M.V. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat. Rev. Neurosci. 4 (2003) 299-309
2. Bates B., Rios M., Trumpp A., Chen C., Fan G., Bishop J.M., and Jaenisch R. Neurotrophin-3 is required for proper cerebellar development. Nat. Neurosci. 2 (1999) 115-117
3. Sofroniew M.V., Howe C.L., and Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 24 (2001) 1217-1281
4. Monteggia L.M., Barrot M., Powell C.M., Berton O., Galanis V., Gemelli T., Meuth S., Nagy A., Greene R.W., and Nestler E.J. Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc. Natl. Acad. Sci. USA 101 (2004) 10827-10832
5. Akbarian S., Rios M., Liu R.J., Gold S.J., Fong H.F., Zeiler S., Coppola V., Tessarollo L., Jones K.R., Nestler E.J., Aghajanian G.K., and Jaenisch R. Brain-derived neurotrophic factor is essential for opiate-induced plasticity of noradrenergic neurons. J. Neurosci. 22 (2002) 4153-4162
6. Zhang J., Gibney G.T., Zhao P., and Xia Y. Neuroprotective role of delta-opioid receptors in cortical neurons. Am. J. Physiol. Cell Physiol. 282 (2002) C1225-C1234
7. Narita M., Kuzumaki N., Miyatake M., Sato F., Wachi H., Seyama Y., and Suzuki T. Role of delta-opioid receptor function in neurogenesis and neuroprotection. J. Neurochem. 97 (2006) 1494-1505
8. Su T.P. Delta opioid peptide[d-Ala(2), d-Leu(5)]enkephalin promotes cell survival. J. Biomed. Sci. 7 (2000) 195-199
9. Borlongan C.V., Su T.P., and Wang Y. Delta opioid peptide augments functional effects and intrastriatal graft survival of rat fetal ventral mesencephalic cells. Cell Transplant. 10 (2001) 53-58
10. Tsai S.Y., Hayashi T., and Su T.P. Picomolar concentrations of hibernation induction delta opioid peptide [d-Ala2, d-Leu5]enkephalin increase the nerve growth factor in NG-108 cells. Synapse 57 (2005) 179-181
11. Abood M.E., and Tao Q. Characterization of a delta opioid receptor in rat pheochromocytoma cells. J. Pharmacol. Exp. Ther. 274 (1995) 1566-1573
12. Inoue N., and Hatanaka H. Nerve growth factor induces specific enkephalin binding sites in a nerve cell line. J. Biol. Chem. 257 (1982) 9238-9241
13. Chen Y.L., Law P.Y., and Loh H.H. Sustained activation of phosphatidylinositol 3-kinase/Akt/nuclear factor {kappa}B signaling mediates G protein-coupled {delta}-opioid receptor gene expression. J. Biol. Chem. 281 (2006) 3067-3074
14. Greene L.A., and Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73 (1976) 2424-2428
15. Lee N.H., Weinstock K.G., Kirkness E.F., Earle-Hughes J.A., Fuldner R.A., Marmaros S., Glodek A., Gocayne J.D., Adams M.D., Kerlavage A.R., et al. Comparative expressed-sequence-tag analysis of differential gene expression profiles in PC-12 cells before and after nerve growth factor treatment. Proc. Natl. Acad. Sci. USA 92 (1995) 8303-8307
16. Clayton A.L., Rose S., Barratt M.J., and Mahadevan L.C. Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation. EMBO J. 19 (2000) 3714-3726
17. Cheung P., Tanner K.G., Cheung W.L., Sassone-Corsi P., Denu J.M., and Allis C.D. Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol. Cell 5 (2000) 905-915
18. Wong K., Zhang J., Awasthi S., Sharma A., Rogers L., Matlock E.F., Van Lint C., Karpova T., McNally J., and Harrod R. Nerve growth factor receptor signaling induces histone acetyltransferase domain-dependent nuclear translocation of p300/CREB-binding protein-associated factor and hGCN5 acetyltransferases. J. Biol. Chem. 279 (2004) 55667-55674
19. Chen Y.L., Law P.-Y., and Loh H.H. Nuclear factor kappaB signaling in opioid functions and receptor gene expression. J. Neuroimmune. Pharmacol. 1 (2006) 270-279
20. Chen Y.L., Law P.Y., and Loh H.H. Action of NF-kappaB on the delta opioid receptor gene promoter. Biochem. Biophys. Res. Commun. 352 (2007) 818-822
21. Chen Y.L., Law P.Y., and Loh H.H. NGF/PI3K signaling-mediated epigenetic regulation of delta opioid receptor gene expression. Biochem. Biophys. Res. Commun. 368 (2008) 755-760
22. Li Q., and Verma I.M. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2 (2002) 725-734
23. Kaltschmidt B., Widera D., and Kaltschmidt C. Signaling via NF-kappaB in the nervous system. Biochim. Biophys. Acta 1745 (2005) 287-299
24. Zhong H., May M.J., Jimi E., and Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol. Cell 9 (2002) 625-636
25. Hassa P.O., Buerki C., Lombardi C., Imhof R., and Hottiger M.O. Transcriptional coactivation of nuclear factor-kappaB-dependent gene expression by p300 is regulated by poly(ADP)-ribose polymerase-1. J. Biol. Chem. 278 (2003) 45145-45153
26. Augustin L.B., Felsheim R.F., Min B.H., Fuchs S.M., Fuchs J.A., and Loh H.H. Genomic structure of the mouse delta opioid receptor gene. Biochem. Biophys. Res. Commun. 207 (1995) 111-119
27. Zhang Z., Schwartz S., Wagner L., and Miller W. A greedy algorithm for aligning DNA sequences. J. Comput. Biol. 7 (2000) 203-214
28. Xuan Z., Zhao F., Wang J., Chen G., and Zhang M.Q. Genome-wide promoter extraction and analysis in human, mouse, and rat. Genome Biol. 6 (2005) R72
29. Berger S.L. An embarrassment of niches: the many covalent modifications of histones in transcriptional regulation. Oncogene 20 (2001) 3007-3013
30. Neish A.S., Anderson S.F., Schlegel B.P., Wei W., and Parvin J.D. Factors associated with the mammalian RNA polymerase II holoenzyme. Nucleic Acids Res. 26 (1998) 847-853
31. Billon N., van Grunsven L.A., and Rudkin B.B. The CDK inhibitor p21WAF1/Cip1 is induced through a p300-dependent mechanism during NGF-mediated neuronal differentiation of PC12 cells. Oncogene 13 (1996) 2047-2054
32. Kitchen I., Slowe S.J., Matthes H.W., and Kieffer B. Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene. Brain Res. 778 (1997) 73-88
33. Edwards Y.H. CpG islands in genes showing tissue-specific expression. Philos. Trans. R. Soc. Lond. B Biol. Sci. 326 (1990) 207-215
34. Persson A.I., Thorlin T., Bull C., Zarnegar P., Ekman R., Terenius L., and Eriksson P.S. Mu- and delta-opioid receptor antagonists decrease proliferation and increase neurogenesis in cultures of rat adult hippocampal progenitors. Eur. J. Neurosci. 17 (2003) 1159-1172
35. Cameron H.A., Hazel T.G., and McKay R.D. Regulation of neurogenesis by growth factors and neurotransmitters. J. Neurobiol. 36 (1998) 287-306